{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T19:23:21Z","timestamp":1785439401185,"version":"3.56.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["Tabriz University of Medical Sciences"],"award-info":[{"award-number":["Tabriz University of Medical Sciences"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00284-026-05007-9","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:36:14Z","timestamp":1781152574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gut Bacteria: A Beneficial Symbiosis or a Hidden Threat? Investigating the Dual Role of Bacteria in Gastrointestinal Diseases"],"prefix":"10.1007","volume":"83","author":[{"given":"Fatemeh","family":"Soltani-Moghadam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein Samadi","family":"Kafil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Yeghaneh","family":"Sefidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Nezhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Saedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalda","family":"Mohammadzadeh-Asl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Sattarpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ahangarzadeh","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"issue":"8","key":"5007_CR1","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.3390\/ijms21082668","volume":"21","author":"M Matija\u0161i\u0107","year":"2020","unstructured":"Matija\u0161i\u0107 M, Me\u0161trovi\u0107 T, \u010cip\u010di\u0107 Paljetak H, Peri\u0107 M, Bare\u0161i\u0107 A, Verbanac D (2020) Gut microbiota beyond bacteria mycobiome, virome, archaeome, and eukaryotic parasites in IBD. Int J Mol Sci 21(8):2668","journal-title":"Int J Mol Sci"},{"key":"5007_CR2","doi-asserted-by":"publisher","first-page":"1504395","DOI":"10.3389\/fmicb.2025.1504395","volume":"16","author":"Z Huang","year":"2025","unstructured":"Huang Z, Yao Q, Ma S, Zhou J, Wang X, Meng Q, Liu Y, Yu Z, Chen X (2025) The synergistic role of gut microbiota and RNA in metabolic diseases: mechanisms and therapeutic insights. Front Microbiol 16:1504395","journal-title":"Front Microbiol"},{"key":"5007_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas D, De la Fuente MK, Landskron G, Gonz\u00e1lez MJ, Quera R, Dijkstra G, Harmsen HJ, Faber KN, Hermoso MA (2019) Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol 10:277","journal-title":"Front Immunol"},{"issue":"30","key":"5007_CR4","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.3748\/wjg.v28.i30.4053","volume":"28","author":"AEV Quaglio","year":"2022","unstructured":"Quaglio AEV, Grillo TG, De Oliveira ECS, Di Stasi LC, Sassaki LY (2022) Gut microbiota, inflammatory bowel disease and colorectal cancer. World J Gastroenterol 28(30):4053","journal-title":"World J Gastroenterol"},{"issue":"1","key":"5007_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00284-024-03997-y","volume":"82","author":"S Saedi","year":"2025","unstructured":"Saedi S, Derakhshan S, Hasani A, Khoshbaten M, Poortahmasebi V, Milani PG, Sadeghi J (2025) Recent Advances in Gut Microbiome Modulation: Effect of Probiotics, Prebiotics, Synbiotics, and Postbiotics in Inflammatory Bowel Disease Prevention and Treatment. Curr Microbiol 82(1):1\u201313","journal-title":"Curr Microbiol"},{"issue":"2","key":"5007_CR6","doi-asserted-by":"publisher","first-page":"ovaf017","DOI":"10.1093\/lambio\/ovaf017","volume":"78","author":"J Nezhadi","year":"2025","unstructured":"Nezhadi J, Kafil HS, Sadrkabir M, Mahdavi F, Moaddab SY, Nouri R, Mohammadzadeh-Asl Y, Sattarpour S, Rezaee MA (2025) The relationship between pathogenic bacteria and different stages of colorectal cancer. Lett Appl Microbiol 78(2):ovaf017","journal-title":"Lett Appl Microbiol"},{"key":"5007_CR7","doi-asserted-by":"publisher","first-page":"615056","DOI":"10.3389\/fimmu.2020.615056","volume":"11","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Ling Z, Li L (2020) The intestinal microbiota and colorectal cancer. Front Immunol 11:615056","journal-title":"Front Immunol"},{"key":"5007_CR8","unstructured":"Pace F, Pace M, Quartarone G (2020) Probiotics in digestive diseases: focus on Lactobacillus GG. AGA:1"},{"issue":"12","key":"5007_CR9","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.3390\/microorganisms10122382","volume":"10","author":"RMRA Effendi","year":"2022","unstructured":"Effendi RMRA, Anshory M, Kalim H, Dwiyana RF, Suwarsa O, Pardo LM, Nijsten TE, Thio HB (2022) Akkermansia muciniphila and Faecalibacterium prausnitzii in immune-related diseases. Microorganisms 10(12):2382","journal-title":"Microorganisms"},{"issue":"6","key":"5007_CR10","first-page":"703","volume":"74","author":"VN Dargenio","year":"2022","unstructured":"Dargenio VN, Castellaneta S, Panico S, Papagni ME, Dargenio C, Schettini F, Francavilla R, Cristofori F (2022) Probiotics and gastrointestinal diseases. Minerva Pediatr 74(6):703\u2013723","journal-title":"Minerva Pediatr"},{"key":"5007_CR11","doi-asserted-by":"publisher","first-page":"906258","DOI":"10.3389\/fimmu.2022.906258","volume":"13","author":"WK Mousa","year":"2022","unstructured":"Mousa WK, Chehadeh F, Husband S (2022) Microbial dysbiosis in the gut drives systemic autoimmune diseases. Front Immunol 13:906258","journal-title":"Front Immunol"},{"issue":"8","key":"5007_CR12","doi-asserted-by":"publisher","first-page":"ovaf111","DOI":"10.1093\/lambio\/ovaf111","volume":"78","author":"S Saedi","year":"2025","unstructured":"Saedi S, Derakhshan S, Sadeghi J, Hasani A, Khoshbaten M, Poortahmasebi V, Ahmadi S (2025) A study on gut microbiota and short-chain fatty acids in patients with inflammatory bowel disease from northwest Iran. Lett Appl Microbiol 78(8):ovaf111","journal-title":"Lett Appl Microbiol"},{"key":"5007_CR13","doi-asserted-by":"publisher","first-page":"104964","DOI":"10.1016\/j.micpath.2021.104964","volume":"157","author":"D-H Li","year":"2021","unstructured":"Li D-H, Li Z-P, Zhang Y, Zhou G-Z, Ren R-R, Zhao H-J, Zhang N-N, Li J-F, Peng L-H, Yang Y-S (2021) Fecal Fusobacterium nucleatum harbored virulence gene fadA are associated with ulcerative colitis and clinical outcomes. Microb Pathog 157:104964","journal-title":"Microb Pathog"},{"issue":"15","key":"5007_CR14","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.2174\/0113892010338997241216053634","volume":"26","author":"J Nezhadi","year":"2025","unstructured":"Nezhadi J, Kafil HS, Mahdavi F, Sadrkabir M, Hashemzadeh S, Moaddab SY, Nouri R, Mohammadzadeh-Asl Y, Sattarpour S, Rezaee MA (2025) Potential Pathogens Associated with Colorectal Cancer. Curr Pharm Biotechnol 26(15):2420\u20132443","journal-title":"Curr Pharm Biotechnol"},{"issue":"1","key":"5007_CR15","doi-asserted-by":"publisher","first-page":"2295384","DOI":"10.1080\/19490976.2023.2295384","volume":"16","author":"C Martin-Gallausiaux","year":"2024","unstructured":"Martin-Gallausiaux C, Salesse L, Garcia-Weber D, Marinelli L, Beguet-Crespel F, Brochard V, Le Gl\u00e9au C, Jamet A, Dor\u00e9 J, Blotti\u00e8re HM (2024) Fusobacterium nucleatum promotes inflammatory and anti-apoptotic responses in colorectal cancer cells via ADP-heptose release and ALPK1\/TIFA axis activation. Gut Microbes 16(1):2295384","journal-title":"Gut Microbes"},{"issue":"2","key":"5007_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","volume":"14","author":"MR Rubinstein","year":"2013","unstructured":"Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW (2013) Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/\u03b2-catenin signaling via its FadA adhesin. Cell Host Microbe 14(2):195\u2013206","journal-title":"Cell Host Microbe"},{"issue":"2","key":"5007_CR17","doi-asserted-by":"publisher","first-page":"02706","DOI":"10.1128\/mbio","volume":"12","author":"MA Engevik","year":"2021","unstructured":"Engevik MA, Danhof HA, Ruan W, Engevik AC, Chang-Graham AL, Engevik KA, Shi Z, Zhao Y, Brand CK, Krystofiak ES (2021) Fusobacterium nucleatum secretes outer membrane vesicles and promotes intestinal inflammation. MBio 12(2):02706\u201302720. https:\/\/doi.org\/10.1128\/mbio","journal-title":"MBio"},{"key":"5007_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-020-01677-w","volume":"39","author":"P Guo","year":"2020","unstructured":"Guo P, Tian Z, Kong X, Yang L, Shan X, Dong B, Ding X, Jing X, Jiang C, Jiang N (2020) FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2. J Experimental Clin Cancer Res 39:1\u201313","journal-title":"J Experimental Clin Cancer Res"},{"issue":"4","key":"5007_CR19","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1053\/j.gastro.2020.11.034","volume":"160","author":"MA Engevik","year":"2021","unstructured":"Engevik MA, Danhof HA, Auchtung J, Endres BT, Ruan W, Bass\u00e8res E, Engevik AC, Wu Q, Nicholson M, Luna RA (2021) Fusobacterium nucleatum adheres to Clostridioides difficile via the RadD adhesin to enhance biofilm formation in intestinal mucus. Gastroenterology 160(4):1301\u20131314 e1308","journal-title":"Gastroenterology"},{"issue":"6","key":"5007_CR20","doi-asserted-by":"publisher","first-page":"e1581531","DOI":"10.1080\/2162402X.2019.1581531","volume":"8","author":"C Gur","year":"2019","unstructured":"Gur C, Maalouf N, Shhadeh A, Berhani O, Singer BB, Bachrach G, Mandelboim O (2019) Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1. Oncoimmunology 8(6):e1581531","journal-title":"Oncoimmunology"},{"key":"5007_CR21","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1007\/s10096-019-03649-1","volume":"38","author":"AT Kunzmann","year":"2019","unstructured":"Kunzmann AT, Proen\u00e7a MA, Jordao HW, Jiraskova K, Schneiderova M, Levy M, Liska V, Buchler T, Vodickova L, Vymetalkova V (2019) Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients. Eur J Clin Microbiol Infect Dis 38:1891\u20131899","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5007_CR22","doi-asserted-by":"publisher","unstructured":"Martinson JN, Walk ST (2020) Escherichia coli residency in the gut of healthy human adults. EcoSal plus 9(1).https:\/\/doi.org\/10.1128\/ecosalplus. ESP-0003-2020.","DOI":"10.1128\/ecosalplus."},{"issue":"22","key":"5007_CR23","first-page":"fny249","volume":"365","author":"B Dogan","year":"2018","unstructured":"Dogan B, Belcher-Timme HF, Dogan EI, Jiang Z-D, DuPont HL, Snyder N, Yang S, Chandler B, Scherl EJ, Simpson KW (2018) Evaluation of Escherichia coli pathotypes associated with irritable bowel syndrome. FEMS Microbiol Lett 365(22):fny249","journal-title":"FEMS Microbiol Lett"},{"issue":"4","key":"5007_CR24","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s13353-022-00718-8","volume":"63","author":"S Derakhshan","year":"2022","unstructured":"Derakhshan S, Saedi S, Ahmadi A, Hedayati MA (2022) Virulence genes, phylogenetic analysis, and antimicrobial resistance of Escherichia coli isolated from urinary tract infection in hospitalized patients and outpatients. J Appl Genet 63(4):805\u2013813","journal-title":"J Appl Genet"},{"issue":"6","key":"5007_CR25","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1172\/JCI30504","volume":"117","author":"N Barnich","year":"2007","unstructured":"Barnich N, Carvalho FA, Glasser A-L, Darcha C, Jantscheff P, Allez M, Peeters H, Bommelaer G, Desreumaux P, Colombel J-F (2007) CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Investig 117(6):1566\u20131574","journal-title":"J Clin Investig"},{"key":"5007_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fcimb.2012.00081","volume":"2","author":"AR Pacheco","year":"2012","unstructured":"Pacheco AR, Sperandio V (2012) Shiga toxin in enterohemorrhagic E. coli: regulation and novel anti-virulence strategies. Front Cell Infect Microbiol 2:81","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"5007_CR27","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/s41467-021-21162-y","volume":"12","author":"A Iftekhar","year":"2021","unstructured":"Iftekhar A, Berger H, Bouznad N, Heuberger J, Boccellato F, Dobrindt U, Hermeking H, Sigal M, Meyer TF (2021) Genomic aberrations after short-term exposure to colibactin-producing E. coli transform primary colon epithelial cells. Nat Commun 12(1):1003","journal-title":"Nat Commun"},{"key":"5007_CR28","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.3390\/cancers15041152","volume":"15","author":"Y Wang","year":"2023","unstructured":"Wang Y, Fu K (2023) Genotoxins: the mechanistic links between Escherichia coli and colorectal cancer. Cancers (Basel) 15:1152","journal-title":"Cancers (Basel)"},{"issue":"6","key":"5007_CR29","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.3390\/microorganisms12061111","volume":"12","author":"M Sadeghi","year":"2024","unstructured":"Sadeghi M, Mestivier D, Sobhani I (2024) Contribution of pks+ Escherichia coli (E. coli) to Colon Carcinogenesis. Microorganisms 12(6):1111","journal-title":"Microorganisms"},{"issue":"6","key":"5007_CR30","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1053\/j.gastro.2009.02.072","volume":"136","author":"SW Pawlowski","year":"2009","unstructured":"Pawlowski SW, Warren CA, Guerrant R (2009) Diagnosis and treatment of acute or persistent diarrhea. Gastroenterology 136(6):1874\u20131886","journal-title":"Gastroenterology"},{"issue":"4","key":"5007_CR31","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/mi.2017.19","volume":"10","author":"N Zmora","year":"2017","unstructured":"Zmora N, Levy M, Pevsner-Fishcer M, Elinav E (2017) Inflammasomes and intestinal inflammation. Mucosal Immunol 10(4):865\u2013883","journal-title":"Mucosal Immunol"},{"key":"5007_CR32","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.3389\/fmicb.2018.02976","volume":"9","author":"H Deng","year":"2018","unstructured":"Deng H, Yang S, Zhang Y, Qian K, Zhang Z, Liu Y, Wang Y, Bai Y, Fan H, Zhao X (2018) Bacteroides fragilis prevents Clostridium difficile infection in a mouse model by restoring gut barrier and microbiome regulation. Front Microbiol 9:2976","journal-title":"Front Microbiol"},{"issue":"4","key":"5007_CR33","doi-asserted-by":"publisher","first-page":"001156","DOI":"10.1099\/mic.0.001156","volume":"168","author":"S Patrick","year":"2022","unstructured":"Patrick S (2022) A tale of two habitats: Bacteroides fragilis, a lethal pathogen and resident in the human gastrointestinal microbiome. Microbiology 168(4):001156","journal-title":"Microbiology"},{"issue":"9","key":"5007_CR34","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.1128\/IAI.00060-06","volume":"74","author":"S Wu","year":"2006","unstructured":"Wu S, Shin J, Zhang G, Cohen M, Franco A, Sears CL (2006) The Bacteroides fragilis toxin binds to a specific intestinal epithelial cell receptor. Infect Immun 74(9):5382\u20135390","journal-title":"Infect Immun"},{"issue":"4","key":"5007_CR35","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3390\/biomedicines10040827","volume":"10","author":"C-G Lee","year":"2022","unstructured":"Lee C-G, Hwang S, Gwon S-Y, Park C, Jo M, Hong J-E, Rhee K-J (2022) Bacteroides fragilis toxin induces intestinal epithelial cell secretion of interleukin-8 by the e-Cadherin\/\u03b2-Catenin\/NF-\u03baB dependent pathway. Biomedicines 10(4):827","journal-title":"Biomedicines"},{"issue":"1","key":"5007_CR36","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bulcan.2017.10.025","volume":"105","author":"A Bruneau","year":"2017","unstructured":"Bruneau A, Baylatry M-T, Joly AC, Sokol H (2017) Gut microbiota: what impact on colorectal carcinogenesis and treatment? Bull Cancer 105(1):70\u201380","journal-title":"Bull Cancer"},{"issue":"1","key":"5007_CR37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13027-023-00523-w","volume":"18","author":"L Dadgar-Zankbar","year":"2023","unstructured":"Dadgar-Zankbar L, Shariati A, Bostanghadiri N, Elahi Z, Mirkalantari S, Razavi S, Kamali F, Darban-Sarokhalil D (2023) Evaluation of enterotoxigenic Bacteroides fragilis correlation with the expression of cellular signaling pathway genes in Iranian patients with colorectal cancer. Infect agents cancer 18(1):48","journal-title":"Infect agents cancer"},{"issue":"11","key":"5007_CR38","doi-asserted-by":"publisher","first-page":"00312","DOI":"10.1128\/iai","volume":"87","author":"JI Jeon","year":"2019","unstructured":"Jeon JI, Ko SH, Kim JM (2019) Intestinal epithelial cells exposed to Bacteroides fragilis enterotoxin regulate NF-\u03baB activation and inflammatory responses through \u03b2-catenin expression. Infect Immun 87(11):00312\u201300319. https:\/\/doi.org\/10.1128\/iai","journal-title":"Infect Immun"},{"issue":"21","key":"5007_CR39","doi-asserted-by":"publisher","first-page":"11817","DOI":"10.3390\/ijms222111817","volume":"22","author":"JI Jeon","year":"2021","unstructured":"Jeon JI, Lee KH, Kim JM (2021) Bacteroides fragilis enterotoxin upregulates matrix metalloproteinase-7 expression through MAPK and AP-1 activation in intestinal epithelial cells, leading to syndecan-2 release. Int J Mol Sci 22(21):11817","journal-title":"Int J Mol Sci"},{"issue":"10","key":"5007_CR40","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1158\/2159-8290.CD-15-0447","volume":"5","author":"AL Geis","year":"2015","unstructured":"Geis AL, Fan H, Wu X, Wu S, Huso DL, Wolfe JL, Sears CL, Pardoll DM, Housseau F (2015) Regulatory T-cell response to enterotoxigenic Bacteroides fragilis colonization triggers IL17-dependent colon carcinogenesis. Cancer Discov 5(10):1098\u20131109","journal-title":"Cancer Discov"},{"key":"5007_CR41","doi-asserted-by":"publisher","first-page":"102837","DOI":"10.1016\/j.anaerobe.2024.102837","volume":"87","author":"DV Costa","year":"2024","unstructured":"Costa DV, Pham N, Loureiro AV, Yang SE, Behm BW, Warren CA (2024) Clostridioides difficile infection promotes gastrointestinal dysfunction in human and mice post-acute phase of the disease. Anaerobe 87:102837","journal-title":"Anaerobe"},{"issue":"5","key":"5007_CR42","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/microorganisms12051004","volume":"12","author":"E Pourliotopoulou","year":"2024","unstructured":"Pourliotopoulou E, Karampatakis T, Kachrimanidou M (2024) Exploring the Toxin-Mediated Mechanisms in Clostridioides difficile Infection. Microorganisms 12(5):1004","journal-title":"Microorganisms"},{"issue":"5","key":"5007_CR43","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/14787210.2024.2347955","volume":"22","author":"M Tang","year":"2024","unstructured":"Tang M, Wang C, Xia Y, Tang J, Wang J, Shen L (2024) Clostridioides difficile infection in inflammatory bowel disease: A clinical review. Expert Rev Anti-infective Therapy 22(5):297\u2013306","journal-title":"Expert Rev Anti-infective Therapy"},{"key":"5007_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.anaerobe.2018.03.001","volume":"53","author":"K Aktories","year":"2018","unstructured":"Aktories K, Papatheodorou P, Schwan C (2018) Binary Clostridium difficile toxin (CDT)-A virulence factor disturbing the cytoskeleton. Anaerobe 53:21\u201329","journal-title":"Anaerobe"},{"issue":"1","key":"5007_CR45","doi-asserted-by":"publisher","first-page":"2150452","DOI":"10.1080\/21505594.2022.2150452","volume":"14","author":"JE Buddle","year":"2023","unstructured":"Buddle JE, Fagan RP (2023) Pathogenicity and virulence of Clostridioides difficile. Virulence 14(1):2150452","journal-title":"Virulence"},{"issue":"10","key":"5007_CR46","first-page":"6204","volume":"12","author":"Q Xu","year":"2020","unstructured":"Xu Q, Li Y, Zheng Y, Chen Y, Xu X, Wang M (2020) Clostridium difficile toxin B-induced colonic inflammation is mediated by the FOXO3\/PPM1B pathway in fetal human colon epithelial cells. Am J Translational Res 12(10):6204","journal-title":"Am J Translational Res"},{"issue":"7","key":"5007_CR47","doi-asserted-by":"publisher","first-page":"e14339","DOI":"10.1111\/nmo.14339","volume":"34","author":"WL Hasler","year":"2022","unstructured":"Hasler WL, Grabauskas G, Singh P, Owyang C (2022) Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome. Neurogastroenterology Motil 34(7):e14339","journal-title":"Neurogastroenterology Motil"},{"issue":"8","key":"5007_CR48","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1172\/JCI7545","volume":"105","author":"M Warny","year":"2000","unstructured":"Warny M, Keates AC, Keates S, Castagliuolo I, Zacks JK, Aboudola S, Qamar A, Pothoulakis C, LaMont JT, Kelly CP (2000) p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis. J Clin Investig 105(8):1147\u20131156","journal-title":"J Clin Investig"},{"key":"5007_CR49","doi-asserted-by":"crossref","unstructured":"Clayton EM, Rea MC, Shanahan F, Quigley EM, Kiely B, Ross RP, Hill C (2012) Carriage of Clostridium difficile in outpatients with irritable bowel syndrome. J Med Microbiol (9):1290\u20131294","DOI":"10.1099\/jmm.0.040568-0"},{"key":"5007_CR50","doi-asserted-by":"publisher","first-page":"E25","DOI":"10.3390\/toxins8010025","volume":"8","author":"C Fradrich","year":"2016","unstructured":"Fradrich C, Beer L, Gerhard R (2016) Reactive oxygen species as additional determinants for cytotoxicity of Clostridium difficile toxins A and B. Toxins (Basel) 8:E25","journal-title":"Toxins (Basel)"},{"issue":"4","key":"5007_CR51","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/MRM.0000000000000188","volume":"30","author":"J Nezhadi","year":"2019","unstructured":"Nezhadi J, Eslami H, Fakhrzadeh V, Moaddab SR, Zeinalzadeh E, Kafil HS (2019) Photodynamic therapy of infection in burn patients. Reviews Res Med Microbiol 30(4):228\u2013239","journal-title":"Reviews Res Med Microbiol"},{"issue":"1","key":"5007_CR52","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, Zeng C, Zhou T, Zhang J (2024) NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target therapy 9(1):53","journal-title":"Signal Transduct Target therapy"},{"issue":"8","key":"5007_CR53","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","volume":"22","author":"H Mao","year":"2025","unstructured":"Mao H, Zhao X, Sun S-c (2025) NF-\u03baB in inflammation and cancer. Cell Mol Immunol 22(8):811\u2013839","journal-title":"Cell Mol Immunol"},{"key":"5007_CR54","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3389\/fimmu.2020.01387","volume":"11","author":"C Peng","year":"2020","unstructured":"Peng C, Ouyang Y, Lu N, Li N (2020) The NF-\u03baB signaling pathway, the microbiota, and gastrointestinal tumorigenesis: recent advances. Front Immunol 11:1387","journal-title":"Front Immunol"},{"issue":"2","key":"5007_CR55","doi-asserted-by":"publisher","first-page":"G278","DOI":"10.1152\/ajpgi.00126.2018","volume":"316","author":"R Al-Sadi","year":"2019","unstructured":"Al-Sadi R, Youssef M, Rawat M, Guo S, Dokladny K, Haque M, Watterson MD, Ma TY (2019) MMP-9-induced increase in intestinal epithelial tight permeability is mediated by p38 kinase signaling pathway activation of MLCK gene. Am J Physiology-Gastrointestinal Liver Physiol 316(2):G278\u2013G290","journal-title":"Am J Physiology-Gastrointestinal Liver Physiol"},{"key":"5007_CR56","doi-asserted-by":"publisher","first-page":"658681","DOI":"10.3389\/fimmu.2021.658681","volume":"12","author":"L Hu","year":"2021","unstructured":"Hu L, Liu Y, Kong X, Wu R, Peng Q, Zhang Y, Zhou L, Duan L (2021) Fusobacterium nucleatum Facilitates M2 Macrophage Polarization and Colorectal Carcinoma Progression by Activating TLR4\/NF-\u03ba B\/S100A9 Cascade. Front Immunol 12:658681","journal-title":"Front Immunol"},{"issue":"1","key":"5007_CR57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5217\/ir.2023.00080","volume":"22","author":"H Pandey","year":"2024","unstructured":"Pandey H, Jain D, Tang DW, Wong SH, Lal D (2024) Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease. Intestinal Res 22(1):15\u201343","journal-title":"Intestinal Res"},{"issue":"1","key":"5007_CR58","doi-asserted-by":"publisher","first-page":"2431643","DOI":"10.1080\/19490976.2024.2431643","volume":"16","author":"AB Shah","year":"2024","unstructured":"Shah AB, Baiseitova A, Zahoor M, Ahmad I, Ikram M, Bakhsh A, Shah MA, Ali I, Idress M, Ullah R (2024) Probiotic significance of Lactobacillus strains: A comprehensive review on health impacts, research gaps, and future prospects. Gut Microbes 16(1):2431643","journal-title":"Gut Microbes"},{"issue":"2","key":"5007_CR59","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.cgh.2018.09.028","volume":"17","author":"EM Quigley","year":"2019","unstructured":"Quigley EM (2019) Prebiotics and probiotics in digestive health. Clin Gastroenterol Hepatol 17(2):333\u2013344","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5007_CR60","doi-asserted-by":"publisher","first-page":"1187911","DOI":"10.3389\/fphar.2023.1187911","volume":"14","author":"W Jin","year":"2023","unstructured":"Jin W, Ai H, Huang Q, Li C, He X, Jin Z, Zuo Y (2023) Preclinical evidence of probiotics in ulcerative colitis: A systematic review and network meta-analysis. Front Pharmacol 14:1187911","journal-title":"Front Pharmacol"},{"key":"5007_CR61","doi-asserted-by":"publisher","first-page":"833906","DOI":"10.3389\/fnut.2022.833906","volume":"9","author":"J Yang","year":"2022","unstructured":"Yang J, Sun Y, Gao T, Wu Y, Sun H, Zhu Q, Liu C, Zhou C, Han Y, Tao Y (2022) Fermentation and storage characteristics of Fuji apple juice using Lactobacillus acidophilus, Lactobacillus casei and Lactobacillus plantarum: Microbial growth, metabolism of bioactives and in vitro bioactivities. Front Nutr 9:833906","journal-title":"Front Nutr"},{"issue":"36","key":"5007_CR62","doi-asserted-by":"publisher","first-page":"5973","DOI":"10.3748\/wjg.v19.i36.5973","volume":"19","author":"C Dai","year":"2013","unstructured":"Dai C, Zheng C-Q, Jiang M, Ma X-Y, Jiang L-J (2013) Probiotics and irritable bowel syndrome. World J Gastroenterology: WJG 19(36):5973","journal-title":"World J Gastroenterology: WJG"},{"issue":"1","key":"5007_CR63","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/joim.12591","volume":"282","author":"NY Lai","year":"2017","unstructured":"Lai NY, Mills K, Chiu IM (2017) Sensory neuron regulation of gastrointestinal inflammation and bacterial host defence. J Intern Med 282(1):5\u201323","journal-title":"J Intern Med"},{"issue":"5","key":"5007_CR64","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.dld.2019.12.009","volume":"52","author":"S Sadrin","year":"2020","unstructured":"Sadrin S, Sennoune S, Gout B, Marque S, Moreau J, Zinoune K, Grillasca J-P, Pons O, Maixent J-M (2020) A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial. Dig Liver Disease 52(5):534\u2013540","journal-title":"Dig Liver Disease"},{"issue":"1","key":"5007_CR65","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1365-2036.2007.03542.x","volume":"27","author":"K Kajander","year":"2008","unstructured":"Kajander K, Myllyluoma E, RAJILI\u0106-STOJANOVI\u0106 M, Kyr\u00f6npalo S, Rasmussen M, J\u00e4rvenp\u00e4\u00e4 S, Zoetendal EG, de Vos WM, Vapaatalo H, Korpela R (2008) Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther 27(1):48\u201357","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"5007_CR66","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41420-023-01666-w","volume":"9","author":"C Li","year":"2023","unstructured":"Li C, Peng K, Xiao S, Long Y, Yu Q (2023) The role of Lactobacillus in inflammatory bowel disease: from actualities to prospects. Cell Death Discovery 9(1):361","journal-title":"Cell Death Discovery"},{"key":"5007_CR67","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.aninu.2021.09.012","volume":"9","author":"J Ma","year":"2022","unstructured":"Ma J, Piao X, Mahfuz S, Long S, Wang J (2022) The interaction among gut microbes, the intestinal barrier and short chain fatty acids. Anim Nutr 9:159\u2013174","journal-title":"Anim Nutr"},{"issue":"4","key":"5007_CR68","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1046\/j.1462-5822.2003.t01-1-00275.x","volume":"5","author":"JA Pena","year":"2003","unstructured":"Pena JA, Versalovic J (2003) Lactobacillus rhamnosus GG decreases TNF-\u03b1 production in lipopolysaccharide\u2010activated murine macrophages by a contact\u2010independent mechanism. Cell Microbiol 5(4):277\u2013285","journal-title":"Cell Microbiol"},{"issue":"6","key":"5007_CR69","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3390\/nu10060691","volume":"10","author":"A Reyes-D\u00edaz","year":"2018","unstructured":"Reyes-D\u00edaz A, Mata-Haro V, Hern\u00e1ndez J, Gonz\u00e1lez-C\u00f3rdova AF, Hern\u00e1ndez-Mendoza A, Reyes-D\u00edaz R, Torres-Llanez MJ, Beltr\u00e1n-Barrientos LM, Vallejo-Cordoba B (2018) Milk fermented by specific lactobacillus strains regulates the serum levels of IL-6, TNF-\u03b1 and IL-10 cytokines in a LPS-stimulated murine model. Nutrients 10(6):691","journal-title":"Nutrients"},{"issue":"1","key":"5007_CR70","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/ibd.21709","volume":"18","author":"ER Petersen","year":"2012","unstructured":"Petersen ER, Claesson MH, Schmidt EGW, Jensen SS, Ravn P, Olsen J, Ouwehand AC, Kristensen NN (2012) Consumption of probiotics increases the effect of regulatory T cells in transfer colitis. Inflamm Bowel Dis 18(1):131\u2013142","journal-title":"Inflamm Bowel Dis"},{"key":"5007_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-020-03740-8","volume":"470","author":"R Ghanavati","year":"2020","unstructured":"Ghanavati R, Akbari A, Mohammadi F, Asadollahi P, Javadi A, Talebi M, Rohani M (2020) Lactobacillus species inhibitory effect on colorectal cancer progression through modulating the Wnt\/\u03b2-catenin signaling pathway. Mol Cell Biochem 470:1\u201313","journal-title":"Mol Cell Biochem"},{"issue":"1\u20132","key":"5007_CR72","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ijpharm.2016.12.005","volume":"517","author":"M Fredua-Agyeman","year":"2017","unstructured":"Fredua-Agyeman M, Stapleton P, Basit AW, Beezer AE, Gaisford S (2017) In vitro inhibition of Clostridium difficile by commercial probiotics: a microcalorimetric study. Int J Pharm 517(1\u20132):96\u2013103","journal-title":"Int J Pharm"},{"issue":"3","key":"5007_CR73","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3390\/antiox12030769","volume":"12","author":"T Zhao","year":"2023","unstructured":"Zhao T, Wang H, Liu Z, Liu Y, DeJi, Li B, Huang X (2023) Recent perspective of Lactobacillus in reducing oxidative stress to prevent disease. Antioxidants 12(3):769","journal-title":"Antioxidants"},{"issue":"26","key":"5007_CR74","doi-asserted-by":"publisher","first-page":"8048","DOI":"10.1080\/10408398.2022.2054934","volume":"63","author":"B-L He","year":"2023","unstructured":"He B-L, Xiong Y, Hu T-G, Zong M-H, Wu H (2023) Bifidobacterium spp. as functional foods: A review of current status, challenges, and strategies. Crit Rev Food Sci Nutr 63(26):8048\u20138065","journal-title":"Crit Rev Food Sci Nutr"},{"key":"5007_CR75","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.3389\/fmicb.2017.02345","volume":"8","author":"L Ruiz","year":"2017","unstructured":"Ruiz L, Delgado S, Ruas-Madiedo P, S\u00e1nchez B, Margolles A (2017) Bifidobacteria and their molecular communication with the immune system. Front Microbiol 8:2345","journal-title":"Front Microbiol"},{"issue":"2","key":"5007_CR76","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1039\/D4FO03710C","volume":"16","author":"L Wang","year":"2025","unstructured":"Wang L, Cao L, Yu Q, Liang M, Yang Z, Wang G, Zhao J, Chen W (2025) Bifidobacterium bifidum CCFM1359 alleviates intestinal motility disorders through the BDNF-TrkB pathway. Food Funct 16(2):437\u2013451","journal-title":"Food Funct"},{"issue":"7","key":"5007_CR77","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.3390\/microorganisms10071332","volume":"10","author":"T Mazzawi","year":"2022","unstructured":"Mazzawi T (2022) Gut microbiota manipulation in irritable bowel syndrome. Microorganisms 10(7):1332","journal-title":"Microorganisms"},{"key":"5007_CR78","doi-asserted-by":"publisher","first-page":"976406","DOI":"10.3389\/fmicb.2022.976406","volume":"13","author":"Z Zhan","year":"2022","unstructured":"Zhan Z, Tang H, Zhang Y, Huang X, Xu M (2022) Potential of gut-derived short-chain fatty acids to control enteric pathogens. Front Microbiol 13:976406","journal-title":"Front Microbiol"},{"issue":"1","key":"5007_CR79","first-page":"8030297","volume":"2021","author":"S Yao","year":"2021","unstructured":"Yao S, Zhao Z, Wang W, Liu X (2021) Bifidobacterium longum: protection against inflammatory bowel disease. J Immunol Res 2021(1):8030297","journal-title":"J Immunol Res"},{"issue":"9","key":"5007_CR80","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.ajpath.2024.05.012","volume":"194","author":"R Abdulqadir","year":"2024","unstructured":"Abdulqadir R, Al-Sadi R, Haque M, Gupta Y, Rawat M, Ma TY (2024) Bifidobacterium bifidum Strain BB1 Inhibits Tumor Necrosis Factor-\u03b1\u2013Induced Increase in Intestinal Epithelial Tight Junction Permeability via Toll-Like Receptor-2\/Toll-Like Receptor-6 Receptor Complex\u2013Dependent Stimulation of Peroxisome Proliferator-Activated Receptor \u03b3 and Suppression of NF-\u03baB p65. Am J Pathol 194(9):1664\u20131683","journal-title":"Am J Pathol"},{"key":"5007_CR81","doi-asserted-by":"crossref","unstructured":"Daneshpour N (2024) Bifidobacterium and the Immune System: A Key Player Against Gastrointestinal Cancers. J Microbiota 1(3):e154264","DOI":"10.5812\/jmb-154264"},{"issue":"12","key":"5007_CR82","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.4014\/jmb.2007.07046","volume":"30","author":"HJ Lim","year":"2020","unstructured":"Lim HJ, Shin HS (2020) Antimicrobial and immunomodulatory effects of Bifidobacterium strains: A review. J Microbiol Biotechnol 30(12):1793","journal-title":"J Microbiol Biotechnol"},{"issue":"1","key":"5007_CR83","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/s41598-024-83048-5","volume":"15","author":"MJ Kim","year":"2025","unstructured":"Kim MJ, Song M-H, Ji Y-S, Park JW, Shin Y-K, Kim S-C, Kim G, Cho B, Park H, Ku J-L (2025) Cell free supernatants of Bifidobacterium adolescentis and Bifidobacterium longum suppress the tumor growth in colorectal cancer organoid model. Sci Rep 15(1):935","journal-title":"Sci Rep"},{"issue":"1","key":"5007_CR84","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12866-025-03775-1","volume":"25","author":"J Yin","year":"2025","unstructured":"Yin J, Chen L, Lin Y, Qiu J, Liu F, Wang Y, Dou X (2025) Bifidobacterium bifidum reduces oxidative stress and alters gut flora to mitigate acute liver injury caused by N-acetyl-p-aminophenol. BMC Microbiol 25(1):87","journal-title":"BMC Microbiol"},{"issue":"9","key":"5007_CR85","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.4014\/jmb.2206.06023","volume":"32","author":"YJ Choi","year":"2022","unstructured":"Choi YJ, Shin S-H, Shin HS (2022) Immunomodulatory Effects of Bifidobacterium spp. and Use of Bifidobacterium breve and Bifidobacterium longum on Acute Diarrhea in Children. J Microbiol Biotechnol 32(9):1186","journal-title":"J Microbiol Biotechnol"},{"issue":"6","key":"5007_CR86","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1099\/00207713-52-6-2141","volume":"52","author":"SH Duncan","year":"2002","unstructured":"Duncan SH, Hold GL, Harmsen HJ, Stewart CS, Flint HJ (2002) Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int J Syst Evol MicroBiol 52(6):2141\u20132146","journal-title":"Int J Syst Evol MicroBiol"},{"issue":"4","key":"5007_CR87","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/ismej.2016.176","volume":"11","author":"M Lopez-Siles","year":"2017","unstructured":"Lopez-Siles M, Duncan SH, Garcia-Gil LJ, Martinez-Medina M (2017) Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J 11(4):841\u2013852","journal-title":"ISME J"},{"issue":"7","key":"5007_CR88","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.3390\/cells10071775","volume":"10","author":"PS Salvi","year":"2021","unstructured":"Salvi PS, Cowles RA (2021) Butyrate and the intestinal epithelium: modulation of proliferation and inflammation in homeostasis and disease. Cells 10(7):1775","journal-title":"Cells"},{"key":"5007_CR89","doi-asserted-by":"crossref","unstructured":"Sokol H, Pigneur B, Watterlot L, Lakhdari O, Berm\u00fadez-Humar\u00e1n LG, Gratadoux J-J, Blugeon S, Bridonneau C, Furet J-P, Corthier G (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proceedings of the National Academy of Sciences 105(43):16731\u201316736","DOI":"10.1073\/pnas.0804812105"},{"issue":"1","key":"5007_CR90","doi-asserted-by":"publisher","first-page":"19399","DOI":"10.1038\/srep19399","volume":"6","author":"S Miquel","year":"2016","unstructured":"Miquel S, Mart\u00edn R, Lashermes A, Gillet M, Meleine M, Gelot A, Eschalier A, Ardid D, Berm\u00fadez-Humar\u00e1n L, Sokol H (2016) Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models. Sci Rep 6(1):19399","journal-title":"Sci Rep"},{"issue":"1","key":"5007_CR91","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3390\/medicina61010136","volume":"61","author":"AL Mederle","year":"2025","unstructured":"Mederle AL, Semenescu A, Dr\u0103ghici GA, Dehelean CA, Vl\u0103du\u021b N-V, Nica DV (2025) Sodium Butyrate: A Multifaceted Modulator in Colorectal Cancer Therapy. Medicina 61(1):136","journal-title":"Medicina"},{"issue":"5","key":"5007_CR92","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.3390\/biomedicines10051128","volume":"10","author":"IJ Dikeocha","year":"2022","unstructured":"Dikeocha IJ, Al-Kabsi AM, Chiu H-T, Alshawsh MA (2022) Faecalibacterium prausnitzii ameliorates colorectal tumorigenesis and suppresses proliferation of HCT116 colorectal cancer cells. Biomedicines 10(5):1128","journal-title":"Biomedicines"},{"issue":"5","key":"5007_CR93","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1099\/mic.0.000444","volume":"163","author":"WM de Vos","year":"2017","unstructured":"de Vos WM (2017) Microbe profile: Akkermansia muciniphila: a conserved intestinal symbiont that acts as the gatekeeper of our mucosa. Microbiology 163(5):646\u2013648","journal-title":"Microbiology"},{"issue":"6","key":"5007_CR94","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/1751-7915.13410","volume":"12","author":"T Zhang","year":"2019","unstructured":"Zhang T, Li Q, Cheng L, Buch H, Zhang F (2019) Akkermansia muciniphila is a promising probiotic. Microb Biotechnol 12(6):1109\u20131125","journal-title":"Microb Biotechnol"},{"key":"5007_CR95","doi-asserted-by":"publisher","first-page":"934695","DOI":"10.3389\/fimmu.2022.934695","volume":"13","author":"VF Rodrigues","year":"2022","unstructured":"Rodrigues VF, Elias-Oliveira J, Pereira \u00cdS, Pereira JA, Barbosa SC, Machado MSG, Carlos D (2022) Akkermansia muciniphila and gut immune system: a good friendship that attenuates inflammatory bowel disease, obesity, and diabetes. Front Immunol 13:934695","journal-title":"Front Immunol"},{"issue":"23","key":"5007_CR96","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1097\/CM9.0000000000001829","volume":"134","author":"Z-Y Gu","year":"2021","unstructured":"Gu Z-Y, Pei W-L, Zhang Y, Zhu J, Li L, Zhang Z (2021) Akkermansia muciniphila in inflammatory bowel disease and colorectal cancer. Chin Med J 134(23):2841\u20132843","journal-title":"Chin Med J"},{"key":"5007_CR97","doi-asserted-by":"publisher","first-page":"788638","DOI":"10.3389\/fimmu.2021.788638","volume":"12","author":"Y Luo","year":"2021","unstructured":"Luo Y, Lan C, Xie K, Li H, Devillard E, He J, Liu L, Cai J, Tian G, Wu A (2021) Active or autoclaved Akkermansia muciniphila relieves TNF-\u03b1-induced inflammation in intestinal epithelial cells through distinct pathways. Front Immunol 12:788638","journal-title":"Front Immunol"},{"issue":"1","key":"5007_CR98","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s42003-024-05867-6","volume":"7","author":"A Pe\u00f1a-Cearra","year":"2024","unstructured":"Pe\u00f1a-Cearra A, Palacios A, Pellon A, Castelo J, Pasco ST, Seoane I, Barriales D, Martin JE, Pascual-Itoiz M\u00c1, Gonzalez-Lopez M (2024) Akkermansia muciniphila-induced trained immune phenotype increases bacterial intracellular survival and attenuates inflammation. Commun Biology 7(1):192","journal-title":"Commun Biology"},{"key":"5007_CR99","doi-asserted-by":"publisher","first-page":"1024393","DOI":"10.3389\/fgstr.2022.1024393","volume":"1","author":"R Iwaza","year":"2022","unstructured":"Iwaza R, Wasfy RM, Dubourg G, Raoult D, Lagier J-C (2022) Akkermansia muciniphila: The state of the art, 18 years after its first discovery. Front Gastroenterol 1:1024393","journal-title":"Front Gastroenterol"},{"issue":"1","key":"5007_CR100","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13099-024-00635-7","volume":"16","author":"C Mo","year":"2024","unstructured":"Mo C, Lou X, Xue J, Shi Z, Zhao Y, Wang F, Chen G (2024) The influence of Akkermansia muciniphila on intestinal barrier function. Gut Pathogens 16(1):41","journal-title":"Gut Pathogens"},{"issue":"8","key":"5007_CR101","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.2337\/db14-1916","volume":"64","author":"DE Roopchand","year":"2015","unstructured":"Roopchand DE, Carmody RN, Kuhn P, Moskal K, Rojas-Silva P, Turnbaugh PJ, Raskin I (2015) Dietary polyphenols promote growth of the gut bacterium Akkermansia muciniphila and attenuate high-fat diet\u2013induced metabolic syndrome. Diabetes 64(8):2847\u20132858","journal-title":"Diabetes"},{"issue":"11","key":"5007_CR102","doi-asserted-by":"publisher","first-page":"6022","DOI":"10.3390\/ijms25116022","volume":"25","author":"P Chandrasekaran","year":"2024","unstructured":"Chandrasekaran P, Weiskirchen S, Weiskirchen R (2024) Effects of probiotics on gut microbiota: an overview. Int J Mol Sci 25(11):6022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"5007_CR103","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1111\/mmi.14905","volume":"117","author":"S Hertli","year":"2022","unstructured":"Hertli S, Zimmermann P (2022) Molecular interactions between the intestinal microbiota and the host. Mol Microbiol 117(6):1297\u20131307","journal-title":"Mol Microbiol"},{"issue":"12","key":"5007_CR104","doi-asserted-by":"publisher","first-page":"ovae127","DOI":"10.1093\/lambio\/ovae127","volume":"77","author":"J Nezhadi","year":"2024","unstructured":"Nezhadi J, Ahmadi A (2024) Assessing the efficacy of postbiotics derived from Lactobacillus plantarum on antibiotic resistance genes in nosocomial pathogens such as Enterococcus faecalis and Pseudomonas aeruginosa. Lett Appl Microbiol 77(12):ovae127","journal-title":"Lett Appl Microbiol"},{"issue":"8","key":"5007_CR105","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.3390\/microorganisms11081898","volume":"11","author":"C Thoda","year":"2023","unstructured":"Thoda C, Touraki M (2023) Probiotic-derived bioactive compounds in colorectal cancer treatment. Microorganisms 11(8):1898","journal-title":"Microorganisms"},{"key":"5007_CR106","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fcimb.2015.00026","volume":"5","author":"Q Yu","year":"2015","unstructured":"Yu Q, Yuan L, Deng J, Yang Q (2015) Lactobacillus protects the integrity of intestinal epithelial barrier damaged by pathogenic bacteria. Front Cell Infect Microbiol 5:26","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"5007_CR107","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/metabo14010074","volume":"14","author":"B Gurung","year":"2024","unstructured":"Gurung B, Stricklin M, Wang S (2024) Gut microbiota\u2013gut metabolites and Clostridioides difficile infection: approaching sustainable solutions for therapy. Metabolites 14(1):74","journal-title":"Metabolites"},{"key":"5007_CR108","doi-asserted-by":"crossref","unstructured":"Wang G, Ding T, Ai L (2024) Effects and mechanisms of probiotics, prebiotics, synbiotics and postbiotics on intestinal health and disease. In. Front Media SA, p 1430312","DOI":"10.3389\/fcimb.2024.1430312"},{"issue":"16","key":"5007_CR109","doi-asserted-by":"publisher","first-page":"9026","DOI":"10.3390\/ijms25169026","volume":"25","author":"S Hamamah","year":"2024","unstructured":"Hamamah S, Lobiuc A, Covasa M (2024) Antioxidant Role of Probiotics in Inflammation-Induced Colorectal Cancer. Int J Mol Sci 25(16):9026","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5007_CR110","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1053\/j.gastro.2020.05.060","volume":"159","author":"GA Preidis","year":"2020","unstructured":"Preidis GA, Weizman AV, Kashyap PC, Morgan RL (2020) AGA technical review on the role of probiotics in the management of gastrointestinal disorders. Gastroenterology 159(2):708\u2013738 e704","journal-title":"Gastroenterology"},{"key":"5007_CR111","doi-asserted-by":"crossref","unstructured":"Montgomery TL, K\u00fcnstner A, Kennedy JJ, Fang Q, Asarian L, Culp-Hill R, D\u2019Alessandro A, Teuscher C, Busch H, Krementsov DN (2020) Interactions between host genetics and gut microbiota determine susceptibility to CNS autoimmunity. Proceedings of the National Academy of Sciences 117(44):27516\u201327527","DOI":"10.1073\/pnas.2002817117"},{"key":"5007_CR112","doi-asserted-by":"crossref","unstructured":"McFarland LV, Karakan T, Karatas A (2021) Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis. EClinicalMedicine 41","DOI":"10.1016\/j.eclinm.2021.101154"},{"key":"5007_CR113","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.coph.2019.03.016","volume":"49","author":"T Uzbay","year":"2019","unstructured":"Uzbay T (2019) Germ-free animal experiments in the gut microbiota studies. Curr Opin Pharmacol 49:6\u201310","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"5007_CR114","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cels.2022.12.010","volume":"14","author":"Y-Y Liu","year":"2023","unstructured":"Liu Y-Y (2023) Controlling the human microbiome. Cell Syst 14(2):135\u2013159","journal-title":"Cell Syst"},{"issue":"22","key":"5007_CR115","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.3390\/nu16223806","volume":"16","author":"A Abeltino","year":"2024","unstructured":"Abeltino A, Hatem D, Serantoni C, Riente A, De Giulio MM, De Spirito M, De Maio F, Maulucci G (2024) Unraveling the gut microbiota: implications for precision nutrition and personalized medicine. Nutrients 16(22):3806","journal-title":"Nutrients"},{"issue":"1","key":"5007_CR116","doi-asserted-by":"publisher","first-page":"12955","DOI":"10.1038\/srep12955","volume":"5","author":"J Landy","year":"2015","unstructured":"Landy J, Walker A, Li J, Al-Hassi HO, Ronde E, English N, Mann E, Bernardo D, McLaughlin S, Parkhill J (2015) Variable alterations of the microbiota, without metabolic or immunological change, following faecal microbiota transplantation in patients with chronic pouchitis. Sci Rep 5(1):12955","journal-title":"Sci Rep"},{"issue":"6","key":"5007_CR117","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/myc.12604","volume":"60","author":"U Roy","year":"2017","unstructured":"Roy U, Jessani LG, Rudramurthy SM, Gopalakrishnan R, Dutta S, Chakravarty C, Jillwin J, Chakrabarti A (2017) Seven cases of Saccharomyces fungaemia related to use of probiotics. Mycoses 60(6):375\u2013380","journal-title":"Mycoses"},{"issue":"19","key":"5007_CR118","doi-asserted-by":"publisher","first-page":"e38088","DOI":"10.1097\/MD.0000000000038088","volume":"103","author":"OP-C Ugwu","year":"2024","unstructured":"Ugwu OP-C, Alum EU, Okon MB, Obeagu EI (2024) Mechanisms of microbiota modulation: Implications for health, disease, and therapeutic interventions. Medicine 103(19):e38088","journal-title":"Medicine"},{"issue":"137","key":"5007_CR119","doi-asserted-by":"publisher","first-page":"137rv135","DOI":"10.1126\/scitranslmed.3004183","volume":"4","author":"KP Lemon","year":"2012","unstructured":"Lemon KP, Armitage GC, Relman DA, Fischbach MA (2012) Microbiota-targeted therapies: an ecological perspective. Sci Transl Med 4(137):137rv135\u2013137rv135","journal-title":"Sci Transl Med"},{"issue":"23","key":"5007_CR120","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.3390\/cells13232003","volume":"13","author":"H Seo","year":"2024","unstructured":"Seo H, Kim S, Beck S, Song H-Y (2024) Perspectives on microbiome therapeutics in infectious diseases: A comprehensive approach beyond immunology and microbiology. Cells 13(23):2003","journal-title":"Cells"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-05007-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-026-05007-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-05007-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T10:01:44Z","timestamp":1784800904000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-026-05007-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":120,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5007"],"URL":"https:\/\/doi.org\/10.1007\/s00284-026-05007-9","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"25 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None to be declared.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"414"}}